Prot# AVF3537s / NU JH0711: Phase II Trial of Bevacizumab Combined with Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma

Project: Research project

Project Details

StatusFinished
Effective start/end date4/11/084/11/11

Funding

  • Genentech, Inc (AVF3537s / NU JH0711)